Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study

2023-06-08 15:04:22

Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School

News from our full member the Wilmer Eye Institute – Johns Hopkins

Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.

More information here!

Source and image: Wilmer Eye Institute – Johns Hopkins

More news

News from our full member Moorfields Eye Hospital

Photo made by Simon Harvey New centre reaches the top A significant construction milestone was marked today with a topping out ceremony on the site. The event marked completion of the […]

News from our member L V Prasad Eye Institute

“An Institute, not just an Eye Hospital” The fruits of a clinician-scientist ecosystem This month has been truly special for us, as three of our colleagues have been selected for […]

WAEH February Newsletter

Are you a Human Resources professional and working in a WAEH member eye hospital? Meetings of 2025 The Human Resources Community of practice takes place once every three months. This […]

WAEH Webinar: Setting up an Internet Hospital: Learnings from EYE & ENT Hospital of Fudan University, Shanghai, China

Register now for the WAEH Webinar about the Internet Hospital that has been set up by the EYE & ENT Hospital of Fudan University from Shanghai, China on Wednesday, April […]

News from our member Moorfields Eye Hospital

Genetic therapy gives infants life-changing improvements in sight Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through Moorfields Eye Hospital and […]

Back to News